Clinical Trials
2 trialsNCT00064064 2013-11-06
3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00077415 2013-05-15
3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed